By understanding the mechanisms that drive these disorders, the researchers aim to develop targeted immunotherapies to modulate immune activity and alleviate symptoms.
Engaging with HHS, USDA, CDC for regulatory approvals.
Potential for Emergency Use Authorization (EUA) in veterinary applications.
